US reference laboratory completes ASTar® evaluation

Q-linea AB (publ) (OMX:QLINEA) today announces that a US reference laboratory has completed their analytical evaluation of the ASTar instrument and Gram-negative blood culture panel.

The company is now in discussions with the reference laboratory leadership regarding next steps for implementation of ASTar for routine clinical use. Additional evaluations are ongoing at several US academic medical centers.

Interest in adoption and implementation of the ASTar system continues to grow due to the fully automated nature of the instrument, low hands-on time, high throughput, and ease of use.

Previous communication (May 2nd): https://qlinea.com/mfn_news/q-linea-signs-evaluation-contract-with-reference-laboratory-network-in-the-us/?ln=en

Datum 2024-10-21, kl 08:45
Källa MFN
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.
Cashback är begränsad till högst $100. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.